Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Mais filtros

Base de dados
Tipo de documento
Intervalo de ano de publicação
1.
Acta Gastroenterol Belg ; 84(1): 73-77, 2021.
Artigo em Inglês | MEDLINE | ID: mdl-33639696

RESUMO

Background and study aims: Data on procedural outcome and quality of endoscopic retrograde cholangiopancreatography (ERCP) in Belgian practice are scarce. The aim of this study is to assess current status of ERCP-performance in Belgium. Methods: National multi-institutional survey (online questionnaire) among members of the Belgian Society of Gastrointestinal Endoscopy (BSGIE), conducted in the period June-August 2018. The RIZIV/INAMI provided real-life data on the total number of ERCPs performed in Belgium. Results: Forty-five responders completed the survey (for 43 centers performing ERCP), providing information for 8368 ERCPs performed in 45% (43/95) of institutions performing ERCP in Belgium. Fifty-eight percent of centers performed > 100 ERCPs/year and 7% of centers (n=3) performed < 50 ERCPs/year. According to the RIZIV/INAMI data, low case-volume centers are underrepresented in this survey. The most common ERCPindication was stone extraction (52%). 74% of endoscopists had more than 10 years of experience in performing ERCP. The majority of centers had their own written protocol (84%) for microbiological duodenoscope surveillance. Monitoring of cannulation rate and post-ERCP pancreatitis (PEP) was only performed in a minority of centers (30%). The majority of centers (76%) provided verbal informed consent relating to the ERCP-procedure ; a minority also requested a written informed consent (23%). 65% of centers systematically use NSAIDs for PEP prophylaxis. Conclusion: This is the first survey of ERCP performance in Belgium. There were wide variations in practice. Adherence to key performance measures and measurement and evaluation of ERCP performance in daily practice at center and endoscopist level are not uniformly widespread.


Assuntos
Colangiopancreatografia Retrógrada Endoscópica , Pancreatite , Bélgica/epidemiologia , Colangiopancreatografia Retrógrada Endoscópica/efeitos adversos , Endoscopia Gastrointestinal , Humanos , Inquéritos e Questionários
2.
Eur J Gastroenterol Hepatol ; 10(3): 251-4, 1998 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-9585030

RESUMO

OBJECTIVE: To compare 14 patients with gastric ulcer and Helicobacter heilmannii with other patients with gastric ulcer: age and sex matched patients, patients colonized by Helicobacter pylori and patients on nonsteroidal anti-inflammatory drugs (NSAIDs). SETTING: The endoscopy unit of a university-affiliated hospital. PATIENTS AND METHODS: All patients underwent endoscopy with two antral biopsies and smears from biopsies (touch cytology) in addition to biopsies of ulcers. Most patients had fundic biopsies (n = 10), antral biopsies for culture (n = 7) and/or a urease test (n = 9). Serologic determination of antibodies against H. pylori was obtained in nine patients. RESULTS: Patients with H. heilmannii diagnosed on smears from biopsies (touch cytology) had multiple and antral ulcers in 11 samples, and nodular or irregular lesions in five samples. No patient had a history of peptic ulcer disease. Biopsy revealed mild chronic gastritis in all patients, with features of reactive gastritis in nine. No patient had coexistent infection with H. pylori. Only two of ten patients with follow-up endoscopies had persistent H. heilmannii infection on smear or biopsy. No patient had symptomatic recurrence. Patients with H. pylori infection were older and often had recurrent ulceration. The majority of ulcers associated with NSAIDs occurred in elderly women. CONCLUSIONS: Newly diagnosed gastric ulcers are associated with H. heilmannii infection. Healing is associated with the disappearance of H. heilmannii and the regression of reactive gastritis. Ulcers differ from those associated with H. pylori infection or with the use of NSAIDs, suggesting that H. heilmannii is a possible cause of gastric ulcers.


Assuntos
Infecções por Helicobacter/patologia , Helicobacter/isolamento & purificação , Úlcera Gástrica/microbiologia , Adulto , Fatores Etários , Anti-Inflamatórios não Esteroides/efeitos adversos , Endoscopia , Feminino , Helicobacter/classificação , Helicobacter pylori/isolamento & purificação , Humanos , Masculino , Pessoa de Meia-Idade , Recidiva , Úlcera Gástrica/diagnóstico
3.
Ann Chir ; 50(6): 470-3, 1996.
Artigo em Francês | MEDLINE | ID: mdl-8991204
4.
Acta Gastroenterol Belg ; 58(2): 208-12, 1995.
Artigo em Inglês | MEDLINE | ID: mdl-7571981

RESUMO

The prevalence of Helicobacter pylori gastritis in 36 patients with a perforated ulcer undergoing endoscopy prior to or at least 2 months after perforation was 56%, intermediate between that of age and sex matched healthy blood donors (36%) who had measurement of circulating antibodies to Helicobacter pylori and of ulcer patients without perforation matched for age, sex and ulcer location (86%). In the 20 patients with Helicobacter pylori gastritis, 8 had a history of peptic ulcer and 7 of 9 patients with a follow-up of at least 12 months and no preventive treatment had a symptomatic relapse. The group of patients without infection included 6 young patients (< 40) who did not use non steroidal anti-inflammatory drugs and 10 older patients (> 60): 9 used non steroidal anti-inflammatory drugs and seven had a normal gastric mucosa on biopsy. One patient without Helicobacter pylori had a second perforation, the only relapse in this group. We conclude that patients with perforated ulcers are a heterogeneous group with a recurrent ulcer disease mainly in patients with Helicobacter pylori.


Assuntos
Infecções por Helicobacter/complicações , Úlcera Péptica Perfurada/complicações , Adulto , Idoso , Antibacterianos/administração & dosagem , Antibacterianos/uso terapêutico , Feminino , Gastrite/microbiologia , Infecções por Helicobacter/tratamento farmacológico , Infecções por Helicobacter/microbiologia , Helicobacter pylori , Humanos , Masculino , Pessoa de Meia-Idade , Úlcera Péptica/microbiologia , Recidiva
6.
Arch Pathol Lab Med ; 118(11): 1115-8, 1994 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-7979897

RESUMO

To assess the role of touch cytology (imprint from endoscopic biopsy specimens) in the diagnosis of mucosal infections of the gastrointestinal tract, we reviewed all records and specimens of patients seen during a 30-month period. Touch cytology was performed by rolling biopsy specimens on glass slides. After air fixation, a rapid staining method similar to May-Grünwald-Giemsa was used. The following infections and pathogens were diagnosed (in decreasing order of frequency): Helicobacter pylori gastritis (n = 53), Candida albicans esophagitis (n = 40), Giardia lamblia (n = 13), Gastrospirillum hominis (n = 11), and Blastocystis hominis (n = 8). The smear was positive in 45 patients with H pylori, in 35 patients with C albicans, in nine patients with G lamblia, in 11 patients with G hominis, and in eight patients with B hominis. Cytology was the only positive test in eight, nine, four, seven, and eight patients, respectively, and increased thus the diagnostic yield obtained by histologic examination.


Assuntos
Endoscopia Gastrointestinal/métodos , Mucosa Gástrica , Gastroenteropatias/diagnóstico , Mucosa Intestinal , Animais , Infecções Bacterianas/diagnóstico , Infecções Bacterianas/patologia , Biópsia , Infecções por Blastocystis/diagnóstico , Infecções por Blastocystis/patologia , Blastocystis hominis/isolamento & purificação , Sistema Digestório/microbiologia , Sistema Digestório/parasitologia , Sistema Digestório/patologia , Mucosa Gástrica/microbiologia , Mucosa Gástrica/parasitologia , Mucosa Gástrica/patologia , Gastroenteropatias/microbiologia , Gastroenteropatias/parasitologia , Infecções por Helicobacter/diagnóstico , Infecções por Helicobacter/patologia , Helicobacter heilmannii/isolamento & purificação , Helicobacter pylori/isolamento & purificação , Humanos , Mucosa Intestinal/microbiologia , Mucosa Intestinal/parasitologia , Mucosa Intestinal/patologia , Programas de Rastreamento
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA